Cover Image

Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Florian Tupin, Clarisse Mouriaux, Beatrice Hechler, Kaja Kaastrup, Subra Yegneswaran, Laurence Corash, Pierre H. Mangin
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Transfusion
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complex
by: Florian Tupin, et al.
Published: (2026)

Pathogen‐reduced cryoprecipitate: Early experiences and inventory management
by: C. B. Webb, et al.
Published: (2025)

Understanding the benefits of universal plasma and cryoprecipitate in hospitals in England
by: Melanie Robbins, et al.
Published: (2024)

Transfusion service staff and anesthesiologists prefer pathogen‐reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor
by: Robert A. DeSimone, et al.
Published: (2025)

Establishing a sustainable protocol for massive transfusion using thawed plasma and cryoprecipitate reconstituted from expired thawed plasma
by: Shigeko Nishimura, et al.
Published: (2026)

Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange
by: Sirui Ma, et al.
Published: (2025)

Further thoughts on a lower fibrinogen threshold prior to therapeutic plasma exchange
by: Kamran Urgun, et al.
Published: (2025)

Implementation of pathogen reduced cryoprecipitate for surgical services: A retrospective review of blood product utilization and fibrinogen repletion
by: Joshua Nicholas, et al.
Published: (2025)

Amustaline/glutathione pathogen‐reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial
by: Ian J. Welsby, et al.
Published: (2025)

A novel acridine flow cytometry marker to track post‐transfusion amustaline/glutathione pathogen‐reduced red blood cell survival in sickle cell disease patients
by: Richard J. Benjamin, et al.
Published: (2025)

The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
by: Aaron S. Hess, et al.
Published: (2026)

Exchange transfusion and pre‐filter apheresis dilution for hyperviscosity syndrome refractory to conventional therapeutic plasma exchange in a patient with IgA multiple myeloma
by: Anthony Valin‐Thorburn, et al.
Published: (2025)

A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single‐center analysis
by: Amelework Wodajo, et al.
Published: (2024)

A novel homozygous KEL variant causing K 0 phenotype in a Chinese woman and therapeutic plasma exchange for anti‐Ku removal in preoperative management
by: DanXin Du, et al.
Published: (2025)

Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study
by: Wen Lu, et al.
Published: (2025)

Pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation treated with therapeutic plasma exchange: A case report
by: Abhijit Baheti, et al.
Published: (2025)

Plasma supplemented with glycine is superior to standard plasma in reducing vascular permeability and organ injury via reduction of inflammation in an experimental traumatic shock model
by: Tarık Gözden, et al.
Published: (2026)

On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray
by: Matej Zrimsek, et al.
Published: (2025)

Characterization of allogeneic platelet gel from adult donor blood and umbilical cord blood activated with locally prepared cryoprecipitate and thrombin: A pilot exercise
by: Larysa Mykhailova, et al.
Published: (2026)

The different barriers to donating plasma in plasma donors, whole blood donors, and non‐donors in the United Kingdom
by: Roshan Desai, et al.
Published: (2026)

In vivo genotoxicity assessment of N‐(‐9 acridinyl)‐b‐alanine hydrochloride (S‐300) using a validated Pig‐a mutagenesis assay
by: Anne North, et al.
Published: (2024)

Storage of thawed cryoprecipitate for 5 days at refrigerated temperatures: A systematic review and meta‐analysis
by: Shuhong Xie, et al.
Published: (2025)

SARS‐CoV‐2 IgG antibodies in COVID‐19 convalescent plasma and conventional plasma units
by: Andrew Sulaiman, et al.
Published: (2025)

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery
by: Magali J. Fontaine, et al.
Published: (2025)

Validating transport conditions of fresh frozen plasma units
by: Yigit Baykara, et al.
Published: (2025)

Dried plasma retains hemostatic function and thermal stability during Arctic military operations
by: Kanwal Singh, et al.
Published: (2025)

Amber coloured plasma—Case for illustration
by: Amita Radhakrishnan Nair, et al.
Published: (2024)

Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato‐oncological patients
by: Eva R. Smit, et al.
Published: (2025)

Improved platelet recovery in cryopreserved platelets reconstituted in freeze‐dried plasma
by: Kristina Ehn, et al.
Published: (2026)

Motivations to donate blood and plasma: A scoping review of quantitative studies
by: Pedro Suárez‐Artime, et al.
Published: (2026)

Prevalence of CMV DNA in plasma from United States blood donors
by: Kacie Grimm, et al.
Published: (2025)

Increased mortality in children with severe trauma and bleeding: Hypotheses and methods to reduce the risk
by: Ashley M. Wilson, et al.
Published: (2026)

Four novel ABO*B alleles associated with reduced B antigen expression
by: Yan Li, et al.
Published: (2024)

From shortages to solutions: Liquid plasma as a practical alternative to whole blood for prehospital trauma resuscitation
by: Aashish Rajesh, et al.
Published: (2025)

Microcirculatory perfusion is improved with plasma, but not with crystalloids, in a rat polytraumatic shock model
by: Tarık Gözden, et al.
Published: (2026)

Coagulation factors in spray‐dried plasma: A systematic review and meta‐analysis
by: Biswadev Mitra, et al.
Published: (2025)

Outcomes of massive transfusion recipients administered ABO‐incompatible fresh frozen plasma
by: Joanna Bao‐Ern Loh, et al.
Published: (2024)

Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden
by: Robert Sheppard Nickel, et al.
Published: (2024)

Optimizing Rh immune globulin dosing strategies: Addressing shortages by reducing postpartum overtreatment
by: Sri Bharathi Kavuri, et al.
Published: (2025)

An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product
by: Samantha C. Redden, et al.
Published: (2026)